Results 21 to 30 of about 19,533 (291)

Injections of platelet‐rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia

Skin research and technology, 2023
Platelet‐rich plasma (PRP) has been increasingly accepted as a potential therapy in the treatment of androgenetic alopecia (AGA), However, there remains a dearth of data on the effectiveness of PRP prepared by automatic blood cell separator with a ...
Wei Wei, Yuanjing Zhang, Binman Long, Yuan-Mao Zhang, Chi Zhang, Siping Zhang   +5 more
semanticscholar   +1 more source

Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? [PDF]

Journal of Clinical and Diagnostic Research, 2016
Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions.
Habibullah Aktas, Sevil Alan, Elif Betül Türkoglu, Özge Sevik   +3 more
doaj   +1 more source

Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial

Journal of Cosmetic Dermatology, 2023
Topical minoxidil (MNX) 2%–5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for androgenetic alopecia (AGA). Recently, a 2.2 mg/mL topical formulation of F was developed to minimize the systemic adverse effects ...
A. Rossi, G. Caro
semanticscholar   +1 more source

Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure

Veterinární Medicína, 2022
Minoxidil was originally introduced as a potent vasodilator, but is now widely used as a topical treatment for human alopecia. A 4-year-old neutered male Norwegian Forest cat presented with a 2-day history of anorexia, lethargy, and dyspnoea.
Song JH, Kim SY, Moon JH, Jung DI
doaj   +1 more source

Minoxidil and Dexamethasone Eluting Nanofiber Dressing for Cutaneous Wound Healing in Rat [PDF]

Pharmaceutical Sciences, 2023
Background: Minoxidil is an antihypertensive agent and vasodilator which may help to promote local blood flow thus hastening the closure of excisional skin wounds. Corticosteroids may down-regulate wound healing.
Saber khozan, Behsa Salehian, Fatemeh Montaghimi, Yaeghob Sharifi, Anahita Fathi-Azarbayjani   +4 more
doaj   +1 more source

Androgenetic alopecia: a review [PDF]

, 2017
Purpose Androgenetic alopecia, commonly known as male pattern baldness, is the most common type of progressive hair loss disorder in men. The aim of this paper is to review recent advances in understanding the pathophysiology and molecular mechanism
Caro, Gemma, Fortuna, MARIA CATERINA, Lenzi, Andrea, Lolli, Francesca, Lombardo, Francesco, Pallotti, Francesco, Rossi, Alfredo, Sansone, Andrea   +7 more
core   +1 more source

Comparative studies of the specific activity of soft dosage forms minoxidil for trichological practice

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2023
The treatment and prevention of hair loss have been a serious aesthetic problem for the population for a long time due to the widespread occurrence of the condition and its undesirable medical and social consequences.
V. V. Hladyshev, O. B. Kharaponova, A. D. Diudiun, I. O. Pukhalska, S. A. Hladysheva, A. V. Kurinnyi, H. P. Lysianska   +6 more
doaj   +1 more source

The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial

Journal of Cosmetic Dermatology, 2023
Androgenic alopecia (AGA) is the most common cause of hair loss in women, affecting their quality of life. The present study was conducted with the aim of comparing the combined effect of topical minoxidil and oral spironolactone with the combined effect
Afsaneh Sadeghzadeh Bazargan, Zeynab Tavana, A. Dehghani, Alireza Jafarzadeh, Anahita Tabavar, Ehsan Alavi Rad, A. Goodarzi   +6 more
semanticscholar   +1 more source

Multi-therapies in androgenetic alopecia: review and clinical experiences. [PDF]

, 2016
Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of
Anzalone, Alessia, CARLESIMO, Marta, CARO, GEMMA, FORTUNA, MARIA CATERINA, GARELLI, VALENTINA, PRANTEDA, GIULIA, ROSSI, Alfredo   +6 more
core   +1 more source

Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polymeric and Lipid Nanoparticles for Topical Alopecia Areata Treatment

Pharmaceuticals, 2023
Alopecia areata is managed with oral corticosteroids, which has known side effects for patients. Given that a topical application of formulations containing a corticoid and a substance controlling hair loss progression could reduce or eliminate such ...
B. N. Matos, Ana Luiza Lima, Camila O. Cardoso, Marcílio Cunha-Filho, Taís Gratieri, G. Gelfuso   +5 more
semanticscholar   +1 more source